We found that the downregulation of METTL1 led to decreased m7G level and overexpression of METTL1 led to increased m7G level (Fig. 4H) showing that METTL1 was exactly a m7G writer in bladder cancer. Here, METTL1 is linked to urinary bladder cancer.